{"transactions":[{"id":4622873,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-09-18T20:15:07.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":16509,"price":11.67,"value":192660.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.38 to $12.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":137044,"source":{"system":"sec-edgar","filing":"0001789970-26-000016","document":"form4-09182026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1789970/000178997026000016/form4-09182026_040901.xml","form_type":"4"}},{"id":680818,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-19T22:35:10.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":31395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":31395,"derivative":{"exercise_price":11.245,"expiration_date":"2036-08-16","underlying":"Voting Common Stock","underlying_shares":31395},"source":{"system":"sec-edgar","filing":"0001789970-26-000014","document":"form4-08192026_060806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000014/form4-08192026_060806.xml","form_type":"4"}},{"id":680817,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-08-19T22:35:10.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":7730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of voting common stock of the Issuer."}],"balance_after":153553,"source":{"system":"sec-edgar","filing":"0001789970-26-000014","document":"form4-08192026_060806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000014/form4-08192026_060806.xml","form_type":"4"}},{"id":706313,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-07-18T01:44:28.000Z","date":"2026-07-17","kind":"sale","planned":false,"acquired":false,"shares":1130,"price":37.9,"value":42827.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":145823,"source":{"system":"sec-edgar","filing":"0001789970-26-000012","document":"form4-07182026_010724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000012/form4-07182026_010724.xml","form_type":"4"}},{"id":706312,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-07-18T01:44:28.000Z","date":"2026-07-16","kind":"sale","planned":false,"acquired":false,"shares":11,"price":37.96,"value":417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."}],"balance_after":146953,"source":{"system":"sec-edgar","filing":"0001789970-26-000012","document":"form4-07182026_010724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000012/form4-07182026_010724.xml","form_type":"4"}},{"id":706311,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-07-18T01:44:28.000Z","date":"2026-07-16","kind":"sale","planned":false,"acquired":false,"shares":3331,"price":37.26,"value":124113.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":146964,"source":{"system":"sec-edgar","filing":"0001789970-26-000012","document":"form4-07182026_010724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000012/form4-07182026_010724.xml","form_type":"4"}},{"id":706310,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-07-18T01:44:28.000Z","date":"2026-07-16","kind":"sale","planned":false,"acquired":false,"shares":4776,"price":36.45,"value":174085.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":150295,"source":{"system":"sec-edgar","filing":"0001789970-26-000012","document":"form4-07182026_010724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000012/form4-07182026_010724.xml","form_type":"4"}},{"id":706309,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-07-18T01:44:28.000Z","date":"2026-07-15","kind":"sale","planned":false,"acquired":false,"shares":10,"price":37.54,"value":375.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."}],"balance_after":155071,"source":{"system":"sec-edgar","filing":"0001789970-26-000012","document":"form4-07182026_010724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000012/form4-07182026_010724.xml","form_type":"4"}},{"id":706308,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-07-18T01:44:28.000Z","date":"2026-07-15","kind":"sale","planned":false,"acquired":false,"shares":5103,"price":36.99,"value":188759.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":155081,"source":{"system":"sec-edgar","filing":"0001789970-26-000012","document":"form4-07182026_010724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000012/form4-07182026_010724.xml","form_type":"4"}},{"id":706307,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-07-18T01:44:28.000Z","date":"2026-07-15","kind":"sale","planned":false,"acquired":false,"shares":2147,"price":36,"value":77292.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":160184,"source":{"system":"sec-edgar","filing":"0001789970-26-000012","document":"form4-07182026_010724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000012/form4-07182026_010724.xml","form_type":"4"}},{"id":784198,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-05-12T01:30:10.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":5808,"price":30.56,"value":177492.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.305 to $30.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":162331,"source":{"system":"sec-edgar","filing":"0001789970-26-000010","document":"form4-05112026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000010/form4-05112026_090506.xml","form_type":"4"}},{"id":784197,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-05-12T01:30:10.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":6979,"price":30.04,"value":209649.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.305 to $30.2965 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":168139,"source":{"system":"sec-edgar","filing":"0001789970-26-000010","document":"form4-05112026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000010/form4-05112026_090506.xml","form_type":"4"}},{"id":784196,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-05-12T01:30:10.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":846,"price":28.7,"value":24280.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $29.183 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":175118,"source":{"system":"sec-edgar","filing":"0001789970-26-000010","document":"form4-05112026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000010/form4-05112026_090506.xml","form_type":"4"}},{"id":784195,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-05-12T01:30:10.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":284,"price":27.61,"value":7841.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":175964,"source":{"system":"sec-edgar","filing":"0001789970-26-000010","document":"form4-05112026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000010/form4-05112026_090506.xml","form_type":"4"}},{"id":789430,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-05-07T00:15:08.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":683,"price":30.08,"value":20544.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":176248,"source":{"system":"sec-edgar","filing":"0001789970-26-000008","document":"form4-05062026_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000008/form4-05062026_080503.xml","form_type":"4"}},{"id":789429,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-05-07T00:15:08.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":296,"price":29.56,"value":8749.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.9669 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":176931,"source":{"system":"sec-edgar","filing":"0001789970-26-000008","document":"form4-05062026_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000008/form4-05062026_080503.xml","form_type":"4"}},{"id":789428,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-05-07T00:15:08.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":3908,"price":28.29,"value":110557.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.845 to $28.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":177227,"source":{"system":"sec-edgar","filing":"0001789970-26-000008","document":"form4-05062026_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000008/form4-05062026_080503.xml","form_type":"4"}},{"id":789427,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-05-07T00:15:08.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":9030,"price":27.5,"value":248325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.84 to $27.835 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":181135,"source":{"system":"sec-edgar","filing":"0001789970-26-000008","document":"form4-05062026_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000008/form4-05062026_080503.xml","form_type":"4"}},{"id":805049,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-04-17T20:05:19.000Z","date":"2026-04-16","kind":"sale","planned":false,"acquired":false,"shares":225,"price":27.49,"value":6185.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive."}],"balance_after":190165,"source":{"system":"sec-edgar","filing":"0001789970-26-000006","document":"form4-04172026_040411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000006/form4-04172026_040411.xml","form_type":"4"}},{"id":805048,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-04-17T20:05:19.000Z","date":"2026-04-16","kind":"sale","planned":false,"acquired":false,"shares":73,"price":27.01,"value":1971.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive."}],"balance_after":190390,"source":{"system":"sec-edgar","filing":"0001789970-26-000006","document":"form4-04172026_040411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000006/form4-04172026_040411.xml","form_type":"4"}},{"id":805047,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-04-17T20:05:19.000Z","date":"2026-04-15","kind":"sale","planned":false,"acquired":false,"shares":1529,"price":26.8,"value":40977.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.33 to $27.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (5)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 410 shares acquired under the Issuer's stock purchase plan on March 31, 2026."}],"balance_after":190463,"source":{"system":"sec-edgar","filing":"0001789970-26-000006","document":"form4-04172026_040411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000006/form4-04172026_040411.xml","form_type":"4"}},{"id":913923,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-09T22:50:08.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":31395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the total shares underlying the option shall vest on February 5, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":31395,"derivative":{"exercise_price":15.7,"expiration_date":"2036-02-04","underlying":"Voting Common Stock","underlying_shares":31395},"source":{"system":"sec-edgar","filing":"0001789970-26-000004","document":"form4-02092026_050205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000004/form4-02092026_050205.xml","form_type":"4"}},{"id":913922,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-02-09T22:50:08.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":7730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. 1/4th of the RSUs shall vest on January 1, 2027, and 1/16th of the RSUs shall vest on each subsequent April 1, July 1, October 1 and January 1 thereafter, subject to the Reporting Person's continued service through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of voting common stock of the Issuer."}],"balance_after":191582,"source":{"system":"sec-edgar","filing":"0001789970-26-000004","document":"form4-02092026_050205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000004/form4-02092026_050205.xml","form_type":"4"}},{"id":927655,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2026-01-29T21:30:08.000Z","date":"2026-01-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":26007,"price":17.98,"value":467605.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock unit awards. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025."}],"balance_after":183852,"source":{"system":"sec-edgar","filing":"0001789970-26-000002","document":"form4-01292026_040105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997026000002/form4-01292026_040105.xml","form_type":"4"}},{"id":1012418,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-28T20:15:22.000Z","date":"2025-10-27","kind":"grant","planned":false,"acquired":true,"shares":110046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":110046,"derivative":{"exercise_price":17,"expiration_date":"2035-10-26","underlying":"Voting Common Stock","underlying_shares":110046},"source":{"system":"sec-edgar","filing":"0001789970-25-000008","document":"form4-10282025_041016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997025000008/form4-10282025_041016.xml","form_type":"4"}},{"id":1012417,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Voting Common Stock","published_at":"2025-10-28T20:15:22.000Z","date":"2025-10-27","kind":"grant","planned":false,"acquired":true,"shares":27098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of voting common stock of the Issuer."}],"balance_after":27098,"source":{"system":"sec-edgar","filing":"0001789970-25-000008","document":"form4-10282025_041016.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770069/000178997025000008/form4-10282025_041016.xml","form_type":"4"}},{"id":2258645,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-05-24T17:13:29.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":4831,"price":0.6813,"value":3291.3603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were acquired under the Issuer's Employee Stock Purchase Plan (\"ESPP\") in a transaction that is exempt under both Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP provisions, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 20, 2022."}],"balance_after":8463,"source":{"system":"sec-edgar","filing":"0001169245-22-000076","document":"wf-form4_165342679043260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000076/wf-form4_165342679043260.xml","form_type":"4"}},{"id":2369360,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Legal"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-28T19:19:10.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest in equal monthly installments over 48 months from February 24, 2022, subject to the reporting person's continued service through each such date."}],"balance_after":87500,"derivative":{"exercise_price":1.13,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001169245-22-000007","document":"wf-form4_164609392829155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000007/wf-form4_164609392829155.xml","form_type":"4"}},{"id":2369359,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Legal"}}],"security":"Restricted Stock Unit","published_at":"2022-02-28T19:19:10.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is the economic equivalent of one share of PhaseBio Pharmaceuticals, Inc. common stock and is converted into common stock upon vesting subject to the reporting person's continued service through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These Restricted Stock Units vest in equal one-third amounts on April 1, 2023, 2024, and 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Restricted Stock Units vest in equal one-third amounts on April 1, 2023, 2024, and 2025."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001169245-22-000007","document":"wf-form4_164609392829155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000007/wf-form4_164609392829155.xml","form_type":"4"}},{"id":2498926,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Legal"}}],"security":"Common Stock","published_at":"2021-11-23T18:51:39.000Z","date":"2021-11-19","kind":"grant","acquired":true,"shares":1545,"price":2.01,"value":3105.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3632,"source":{"system":"sec-edgar","filing":"0001169245-21-000126","document":"wf-form4_163771148432425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000126/wf-form4_163771148432425.xml","form_type":"4"}},{"id":2699266,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Legal"}}],"security":"Common Stock","published_at":"2021-05-24T18:09:28.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":1088,"price":2.8,"value":3046.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2087,"source":{"system":"sec-edgar","filing":"0001169245-21-000042","document":"wf-form4_162189414596354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000042/wf-form4_162189414596354.xml","form_type":"4"}},{"id":2872415,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Legal"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-09T16:54:26.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 48 months from February 5, 2021, subject to the reporting person's continued service through each such date."}],"balance_after":36000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001169245-21-000016","document":"wf-form4_161290764216817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000016/wf-form4_161290764216817.xml","form_type":"4"}},{"id":2970086,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Legal"}}],"security":"Common Stock","published_at":"2020-11-23T18:42:11.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":999,"price":3,"value":2997.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":999,"source":{"system":"sec-edgar","filing":"0001169245-20-000104","document":"wf-form4_160617491467923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000104/wf-form4_160617491467923.xml","form_type":"4"}},{"id":3271015,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Head of Legal"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-14T18:50:06.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 48 months from February 12, 2020, subject to the reporting person's continued service through each such date."}],"balance_after":55000,"derivative":{"exercise_price":5.19,"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001169245-20-000029","document":"wf-form4_158172418938967.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000029/wf-form4_158172418938967.xml","form_type":"4"}},{"id":3396720,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":21496,"kind":"person","name":"Hanson Kristopher","position":1,"cik":"0001789970","reported_name":"Hanson Kristopher","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Head of Legal"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-07T19:11:14.000Z","date":"2019-10-07","kind":"grant","acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares vest one year after the grant date; the balance of the shares shall vest in a series of 36 successive equal monthly installments measured from the first anniversary of the grant date, subject to the Reporting Person's continuous service as of each such date."}],"balance_after":66000,"derivative":{"exercise_price":4.17,"expiration_date":"2029-10-07","underlying":"Common Stock","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001209191-19-052721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119052721/doc4.xml","form_type":"4"}}]}